Head-to-head · WeighScore
Enhance MD vs Peter MD
By GLP-1 ScorecardUpdated
Score comparison
Enhance MD has the higher recorded score — 84.8/100 to 78.1/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.
Before you choose
Before comparing the headline prices, the Enhance MD review and the Peter MD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Enhance MD vs Premium Health and Gimme Care vs Peter MD compare each of them with another graded program, and the list of alternatives to Enhance MD ranks the programs closest to Enhance MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Enhance MD | Peter MD |
|---|---|---|
| WeighScore | 84.8/100 | 78.1/100 |
| Grade | B | C+ |
| Site position | #14 | #32 |
| Semaglutide | $249 every 4 weeks on the shortest Core plan; from $212 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge) | From $149/month advertised with B12; other page prices differ; confirm charge and renewal |
| Tirzepatide | $329 every 4 weeks on the shortest Advanced plan; from $280 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge) | From $149/month with B12; $100 off first month advertised; renewal unconfirmed |
| Coverage | FAQ lists 40 states plus DC, subject to product availability; confirm treatment, clinician and pharmacy for your address | Confirm availability for the specific GLP-1 prescription and shipping state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #14 · B
Strengths
- Core and Advanced publish separate short- and longer-plan prices with billing periods stated
- Product pages advertise care, coaching, supplies and six-month labs; baseline labs are described in onboarding
- Terms identify independent medical groups and possible pharmacies rather than only a generic provider network
- The FAQ publishes a product-availability state list and a clinical-ineligibility initial-payment refund policy
What to consider
- Four-week billing and a 48-week longer plan are not twelve calendar-month payments
- First-order discounts differ by term; actual debit, dose, quantity and ongoing schedule require confirmation
- An unused-prepaid-balance refund formula and precise refill cancellation cutoff were not established
- Pharmacy lists differ across public documents; the assigned dispenser and prescriber remain unknown
- One disclosed pharmacy has a closed Oklahoma nonresident permit; this limited finding does not establish company closure or the pharmacy assigned to a patient
- Elite combination and microdose benefit claims were not independently established; no branded or oral GLP-1 offer was established in the reviewed menu
Site position #32 · C+
Strengths
- Dedicated offers advertise consultations, supplies, shipping and membership together
- Public pages name pharmacy possibilities and disclose an email cancellation window
- Laboratory testing is advertised at 50% off
What to consider
- Starting prices do not establish the renewal; main-site price displays differ
- Specific GLP-1 state eligibility, assigned clinician and dispensing pharmacy remain unconfirmed
- Labs are discounted rather than free; GLP-1-specific monitoring and total testing cost remain unclear
- Auto-renewal cancellation requires at least 48 hours’ email notice; sales are final once medication is received
- Clinical rejection and unused-prepayment refund terms remain unresolved
Featured provider
Peter MD
Peter MD scores 78.1/100 (C+). Peter MD advertises B12 injection packages with consultations, supplies and shipping, but its public price displays differ and the ongoing GLP-1 charge needs a written quote.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.